18:44:29 EST Sat 14 Dec 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:IMLFF from 2018-12-14 to 2019-12-13 - 58 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-12-09 08:35IMLFFNews ReleaseGlobal OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
2019-12-09 08:35IMLFFNews ReleaseGlobal OTCQX Consumer and Resource Company Investor Presentations Now Available for On-Demand Viewing
2019-12-09 07:30IMLFFNews ReleaseInMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
2019-12-09 07:30IMLFFNews ReleaseInMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
2019-12-02 08:35IMLFFNews ReleaseLive Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
2019-12-02 08:35IMLFFNews ReleaseLive Investor Conference & Webinar: A Global Portfolio of OTCQX Consumer and Resources Leaders Present December 4th and 5th
2019-11-25 08:35IMLFFNews ReleaseLive Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th
2019-11-25 08:35IMLFFNews ReleaseLive Investor Conference & Webinar: Executives from Resource, Retail, and Cannabis Companies Present December 4th and 5th
2019-11-11 08:30IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Cowen Conference
2019-11-11 08:30IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Cowen Conference
2019-11-08 07:30IMLFFNews ReleaseInMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2019-11-08 07:30IMLFFNews ReleaseInMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
2019-11-05 07:30IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
2019-11-05 07:30IMLFFNews ReleaseInMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
2019-11-04 07:30IMLFFNews ReleaseInMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
2019-11-04 07:30IMLFFNews ReleaseInMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019
2019-10-18 12:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the BIO Investor Forum
2019-10-18 12:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the BIO Investor Forum
2019-09-23 11:00IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
2019-09-23 11:00IMLFFNews ReleaseInMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society's annual conference
2019-09-19 07:30IMLFFNews ReleaseInMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-09-19 07:30IMLFFNews ReleaseInMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-09-12 11:00IMLFFNews ReleaseInMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
2019-09-12 11:00IMLFFNews ReleaseInMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
2019-09-03 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-09-03 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-29 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
2019-08-29 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
2019-08-02 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
2019-08-02 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
2019-07-02 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
2019-07-02 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
2019-06-04 07:00IMLFFNews ReleaseOTC Markets Group Launches OTCQX Cannabis Index
2019-05-15 07:25IMLFFNews ReleaseInMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-05-15 07:25IMLFFNews ReleaseInMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-05-08 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
2019-05-08 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
2019-03-18 07:25IMLFFNews ReleaseInMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
2019-03-18 07:25IMLFFNews ReleaseInMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
2019-03-13 16:01IMLFFNews ReleaseOTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
2019-03-13 07:25IMLFFNews ReleaseInMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
2019-03-13 07:25IMLFFNews ReleaseInMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
2019-03-12 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
2019-03-12 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
2019-03-06 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board
2019-03-06 07:25IMLFFNews ReleaseInMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board
2019-02-12 07:25IMLFFNews ReleaseInMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-02-12 07:25IMLFFNews ReleaseInMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
2019-02-11 14:32IMLFFNews ReleaseWatch These 4 Marijuana Stocks Push Their Limits on Monday (2/11/19)
2019-02-05 13:50IMLFFNews ReleaseThese Marijuana Stocks Should Be On Your Radar
2019-02-05 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
2019-02-05 07:25IMLFFNews ReleaseInMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
2019-02-01 13:52IMLFFNews Release4 Marijuana Stocks Starting Strong On Friday (2/1/19)
2019-01-31 11:46IMLFFNews Release4 Marijuana Stocks Looking To End January On High
2019-01-11 07:25IMLFFNews ReleaseInMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
2019-01-11 07:25IMLFFNews ReleaseInMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
2019-01-03 10:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
2019-01-03 10:25IMLFFNews ReleaseInMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019